Invention Grant
- Patent Title: Lysosomal targeting peptides and uses thereof
-
Application No.: US15657764Application Date: 2017-07-24
-
Publication No.: US11351231B2Publication Date: 2022-06-07
- Inventor: Jonathan LeBowitz , John Maga
- Applicant: BioMarin Pharmaceutical Inc.
- Applicant Address: US CA Novato
- Assignee: BioMarin Pharmaceutical Inc.
- Current Assignee: BioMarin Pharmaceutical Inc.
- Current Assignee Address: US CA Novato
- Agency: Marshall, Gerstein & Borun LLP
- Main IPC: A61K38/47
- IPC: A61K38/47 ; C07K14/65 ; C12N9/26

Abstract:
The present invention provides further improved compositions and methods for efficient lysosomal targeting based on the GILT technology. Among other things, the present invention provides methods and compositions for targeting lysosomal enzymes to lysosomes using furin-resistant lysosomal targeting peptides. The present invention also provides methods and compositions for targeting lysosomal enzymes to lysosomes using a lysosomal targeting peptide that has reduced or diminished binding affinity for the insulin receptor.
Public/Granted literature
- US20180125949A1 Lysosomal Targeting Peptides and Uses Thereof Public/Granted day:2018-05-10
Information query
IPC分类: